JH

Jonas Hansson

Biotech entrepreneur

Greater Stockholm Metropolitan Area

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Education

Work Experience

  • Senior Advisor

    2022

  • Co-founder & CEO

    2022

    Purpose Pharma is a patient-centric European based pharmaceutical company focusing on the development and commercialization of novel rare disease and specialty care products in areas of high unmet medical need.

  • Executive Chairman

    2021

2021

  • Board Member

    2021

2008 - 2022

  • Partner

    2019 - 2022

  • Venture Partner

    2012 - 2019

  • Medical Associate

    2008 - 2012

  • Board Member

    2020 - 2021

2020 - 2021

  • Board Member

    2020 - 2021

  • Senior Advisor

    2018 - 2019

  • Co-founder & CEO

    2012 - 2018

    Co-founding CEO of Wilson Therapeutics. Raised approx USD 100 million in private and public financings. Acquired by Alexion for USD 855 million.

  • Nordic Brand Leader

    2006 - 2008